CLINICAL_TRIALS
trial_result
· 2021-01-14
Clinical Trial Update: Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance [Phase 3]
Summary
Phase 3 clinical trial of Subetta for impaired glucose tolerance has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Materia Medica Holding | Conditions: Impaired Glucose Tolerance | Phase 3 | Status: COMPLETED | Results posted: 2021-01-14